Welcome to LookChem.com Sign In|Join Free
  • or
Benzenesulfonamide, N-(4-chloro-2-iodophenyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

927963-49-3

Post Buying Request

927963-49-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

927963-49-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 927963-49-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,7,9,6 and 3 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 927963-49:
(8*9)+(7*2)+(6*7)+(5*9)+(4*6)+(3*3)+(2*4)+(1*9)=223
223 % 10 = 3
So 927963-49-3 is a valid CAS Registry Number.

927963-49-3Relevant academic research and scientific papers

Triple Mode of Alkylation with Ethyl Bromodifluoroacetate: N, or O-Difluoromethylation, N-Ethylation and S-(ethoxycarbonyl)difluoromethylation

Polley, Arghya,Bairy, Gurupada,Das, Pritha,Jana, Ranjan

, p. 4161 - 4167 (2018)

In this report, we have explored a triple mode of chemical reactivity of ethyl bromodifluoroacetate. Typically, bromodifluoroacetic acid has been used as a difluorocarbene precursor for difluoromethylation of soft nucleophiles. Here we have disclosed nucleophilicity and base dependent divergent chemical reactivity of ethyl bromodifluoroacetate. It furnishes lithium hydroxide and cesium carbonate promoted difluoromethylation of tosyl-protected aniline and electron-deficient phenols respectively. Interestingly, switching the base from lithium hydroxide to 4-N,N-dimethylamino pyridine (DMAP) tosyl-protected anilines afforded the corresponding N-ethylation product. Whereas, highly nucleophilic thiophenols furnished the corresponding S-carboethoxydifluoromethylation product via a rapid SN2 attack to the bromine atom prior to the ester hydrolysis. This mechanistic divergence was established through several control experiments. It was revealed that difluoromethylation reaction proceeds through a tandem in situ ester hydrolysis/decarboxylative-debrominative difluorocarbene formation and subsequent trapping by the soft nucleophile-NHTs or electron-deficient phenolic ?OH groups. In the presence of DMAP the hydrolysis of the ester is perturbed instead a nucleophilic attack at the ethyl moiety provides the N-ethylation product. Hence, besides the development of a practical base-promoted N-difluoromethylation of amines and electron-deficient phenols, divergent reactivity pattern of inexpensive and user-friendly ethyl bromodifluoroacetate has been explored. (Figure presented.).

Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate

Boubia, Bena?ssa,Poupardin, Olivia,Barth, Martine,Binet, Jean,Peralba, Philippe,Mounier, Laurent,Jacquier, Elise,Gauthier, Emilie,Lepais, Valérie,Chatar, Maryline,Ferry, Stéphanie,Thourigny, Anne,Guillier, Fabrice,Llacer, Jonathan,Amaudrut, JéRome,Dodey, Pierre,Lacombe, Olivier,Masson, Philippe,Montalbetti, Christian,Wettstein, Guillaume,Luccarini, Jean-Michel,Legendre, Christiane,Junien, Jean-Louis,Broqua, Pierre

, p. 2246 - 2265 (2018/03/26)

Here, we describe the identification and synthesis of novel indole sulfonamide derivatives that activate the three peroxisome proliferator activated receptor (PPAR) isoforms. Starting with a PPARα activator, compound 4, identified during a high throughput screening (HTS) of our proprietary screening library, a systematic optimization led to the discovery of lanifibranor (IVA337) 5, a moderately potent and well balanced pan PPAR agonist with an excellent safety profile. In vitro and in vivo, compound 5 demonstrated strong activity in models that are relevant to nonalcoholic steatohepatitis (NASH) pathophysiology suggesting therapeutic potential for NASH patients.

Indole Compounds, Method of Preparing Them and Uses Thereof

-

Page/Page column 19, (2008/12/06)

Indole compounds corresponding to the formula (I): as defined in the claims, pharmaceutically acceptable addition salts of such compounds, pharmaceutical compositions containing such compounds, the process for their preparation, and their use as pharmacol

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 927963-49-3